Canton Biologics
PrivateLast Round
Series C
Sep 13, 2023
Total Funding Raised
$56.1M
Company Overview
Canton Biologics is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for biologic drugs, including monoclonal antibodies, bispecific antibodies, and recombinant proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Canton Biologics Comparables
Compare Canton Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioworkshops | 93% | |
| Chime Biologics | 92% | |
| MabPlex | 89% | |
Canton Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 13, 2023 |
Canton Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guangdong Technology Financial Group | Series C |
| SDIC Venture Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2023
$41.1M round led by SDIC Venture Capital.
Canton Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Canton Biologics's valuation, stock price, and market status.